Clinical Safety & Efficacy of a New Infant Formula With Specific Medical Purpose Containing Human Milk Oligosaccharides

NACompletedINTERVENTIONAL
Enrollment

194

Participants

Timeline

Start Date

February 22, 2017

Primary Completion Date

August 7, 2018

Study Completion Date

February 8, 2019

Conditions
Cow's Milk Protein Allergy
Interventions
OTHER

Test infant formula with HMOs

Extensively hydrolysed (whey protein) specialty infant formulas (FSMP) with HMOs intended for management of CMPA.

OTHER

Control infant formula without HMOs

Extensively hydrolysed (whey protein) specialty infant formulas (FSMP) intended for management of CMPA.

Trial Locations (42)

Unknown

Cliniques Universitaires Saint Luc, Brussels

University Hospital Brussels, Brussels

CHC clinique de l'Esperance, Montegnée

Clinexpert Gyogycentrum, Budapest

Bagoly Egeszseghaz, Kecskemét

Csolnoky Ferenc Korhaz, Veszprém

A.O.U Ospedali Riuniti, Ancona

Ospedale Luigi Sacco, Polo Universitario, Milan

University of Naples Federico II, Naples

A.O.U.P - Università degli Studi di Palermo, Palermo

University of Rome La Sapienza, Roma

Prywatna Praktyka Lekarska Gabinet Pediatryczno-Alergologiczny Anna Ploszczuk, Bialystok

Specjalistyczna Przychodnia Lekarska Medicus, Chorzów

Gdańskie Centrum Zdrowia Sp. z o.o., Gdansk

NZOZ Medicus, Gostynin

ATOPIA - Specjalistyczna Przychodnia Medyczna, Krakow

Centrum Medyczne Plejady, Krakow

Gabinet Lekarski Bartosz Korczowski, Rzeszów

Alergo-Med Specjalistyczna Przychodnia Lekarska SP. Z.O.O, Tarnów

Centrum Medyczne Lucyna Andrzej Dymek NZOZ S.C., Zawadzkie

KK Women's and Children's Hospital, Singapore

Mount Elizabeth Medical Centre - Chiang Children's Allergy & Asthma Clinic, Singapore

Mount Elizabeth Medical Centre - The Child and Allergy Clinic, Singapore

National University Hospital, Singapore

Hospital Teresa Herrera, A Coruña

Hospital de Poniente, Almería

EBA Centelles, Barcelona

Hospital de Nens, Barcelona

Hospital Quirónsalud, Barcelona

Hospital Clínico Universitario Virgen de la Arrixaca, Murcia

Buckinghamshire Healthcare NHS Trust, Stoke Mandeville Hospital, Aylesbury

Northern Devon Healthcare NHS Trust, North Devon District Hospital, Barnstaple

Burton Hospitals NHS Foundation Trust, Queen's Hospital, Burton-on-Trent

Epsom and St Helier University Hospitals NHS Trust, St Helier University Hospital, Carshalton

Royal Devon and Exeter NHS Foundation Trust, Exeter

Medway NHS Foundation Trust, Medway Maritime Hospital, Gillingham

James Paget University Hospitals NHS Foundation Trust, Great Yarmouth

Queen Elizabeth Hospital, King's Lynn NHS Foundation Trust, Kings Lynn

The Leeds Teaching Hospitals NHS Trust, Leeds

Chelsea and Westminster Hospital NHS Foundation Trust, London

King's College Hospital NHS Foundation Trust, London

Plymouth Hospitals NHS Trust, Derriford Hospital, Plymouth

All Listed Sponsors
lead

Société des Produits Nestlé (SPN)

INDUSTRY

NCT03085134 - Clinical Safety & Efficacy of a New Infant Formula With Specific Medical Purpose Containing Human Milk Oligosaccharides | Biotech Hunter | Biotech Hunter